# Your Own Painkillers

- Link: https://clearingintheforest.org/your-own-painkillers/
- Published: 2026-10-20T22:00:44+00:00
- Author: Saal_clearingforest

[ 🌲 A clearing in the forest ](https://clearingintheforest.org/)

[ All pages ](https://clearingintheforest.org/?page_id=267#pages)

# Your Own Painkillers

Your body makes its own opioids. They ease pain, calm stress and help you bounce
back after a bad day. This guide explains how that system works, and what two medicines,
low-dose naltrexone and buprenorphine, do to it.

[ 1. The system ](https://clearingintheforest.org/your-own-painkillers/#system)

[ 2. What switches it on ](https://clearingintheforest.org/your-own-painkillers/#switches)

[ 3. Keys & locks ](https://clearingintheforest.org/your-own-painkillers/#keys-locks)

[ 4. Low-dose naltrexone ](https://clearingintheforest.org/your-own-painkillers/#ldn)

[ 5. Buprenorphine ](https://clearingintheforest.org/your-own-painkillers/#buprenorphine)

[ 6. Stay safe ](https://clearingintheforest.org/your-own-painkillers/#stay-safe)

[ 7. Quick quiz ](https://clearingintheforest.org/your-own-painkillers/#quiz)

[ References ](https://clearingintheforest.org/your-own-painkillers/#references)

## Locks and keys inside you

Nerve cells carry tiny **locks** on their surface, called **receptors**. Your body
makes **keys** that fit them. When a key turns a lock, the cell changes what it 
does. Pain signals get quieter, stress settles, or you feel a lift.

Scientists found the locks in 1973 [Ref: Pert & Snyder, Science 1973], and the first
natural keys, the enkephalins, two years later [Ref: Hughes et al., Nature 1975].
Drugs like morphine work only because they happen to fit locks your body already
had.

### Three families of natural keys

Endorphins

The "big" painkiller. Released during injury, stress and hard exercise. Mainly fit
the **mu** lock.

Enkephalins

Small, fast-acting keys in the brain, spinal cord and gut. Fit **delta** and **mu**
locks.

Dynorphins

The "stress brake" keys. Fit the **kappa** lock. Too much makes you feel low and
uneasy.

### Four locks: tap each card

μ

**Mu**tap to flip

**Mu: relief and reward**

Eases pain, gives warmth and pleasure. Also slows breathing, which is why too much
morphine or heroin kills.

δ

**Delta**tap to flip

**Delta: mood and calm**

Linked to lower anxiety and steadier mood in animal studies. Less well understood
in people.

κ

**Kappa**tap to flip

**Kappa: the misery switch**

Turned on by long-term stress. Makes the world feel flat, grim and unrewarding. 
Blocking it is a target for depression treatment.

N

**NOP**tap to flip

**NOP: the odd cousin**

Same family, different key (nociceptin). Its effects on pain are mixed and still
being worked out.

**One-line summary:** mu = relief, kappa = misery, and your brain keeps them in 
balance.

[ Next: what switches it on → ](https://clearingintheforest.org/your-own-painkillers/#switches)

## What switches your painkillers on?

These are three well-known experiments. Each shows the system working in real people.
The grey and red tags tell you how much weight each one can carry: small studies
are interesting, not proof.

### 🏃 Running

Brain-scan study

10 people

No comparison group

Ten athletes had brain scans before and after a two-hour run. After the run, their
own opioids were sitting on the locks in mood and emotion areas. The more euphoric
they felt, the stronger the signal. The "runner's high" is real.

[Ref: Boecker et al., Cerebral Cortex 2008;18(11):2523–31]

### 💊 Belief (the placebo effect)

Randomised, double-blind

Dental surgery patients

After wisdom-tooth surgery, patients given a dummy pill felt less pain. Then they
were given naloxone, a drug that blocks opioid locks. Their pain came back. Only
the patients the dummy pill had helped got worse. So believing a treatment will 
work can make your brain release its own painkillers.

**Important:** this does **not** mean pain is imaginary or "all in your head". The
pain was real, and the relief was real chemistry. Expectation is one more switch
on a real biological system.

[Ref: Levine, Gordon & Fields, Lancet 1978;2(8091):654–7]

Fair warning: a later study showed placebo can also work through non-opioid routes.
Belief uses more than one pathway. [Ref: Grevert, Albert & Goldstein, Pain 1983]

### 💔 Being rejected

Brain-scan study

18 people

In a scanner, volunteers were told people they liked did not like them back. Their
brains released opioids, as if treating a physical injury. People who scored high
on resilience released more.

[Ref: Hsu et al., Molecular Psychiatry 2013;18(11):1211–17]

People with depression released less after rejection, so the hurt lasted longer.

[Ref: Hsu et al., Molecular Psychiatry 2015;20:193–200]

So emotional pain and physical pain share the same repair kit. Exercise, hope and
good relationships all top it up.

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#system)

[ Next: keys & locks → ](https://clearingintheforest.org/your-own-painkillers/#keys-locks)

## Try it: put a key in the mu lock

Not every key does the same thing. Pick one and watch what happens to the lock.

**How hard the lock is switched on**

**How tightly the key grips**

Illustration only. The bar lengths show the idea, not measured values.

Pick a key above.

**Full agonist**

Turns the lock all the way. Strong relief, strong risks. Example: morphine.

**Partial agonist**

Turns it only part-way, however much you take. Example: buprenorphine.

**Antagonist**

Fits the lock and turns nothing. It just blocks other keys. Examples: naloxone, 
naltrexone.

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#switches)

[ Next: low-dose naltrexone → ](https://clearingintheforest.org/your-own-painkillers/#ldn)

## Low-dose naltrexone (LDN)

**⚠ Safety first.** LDN can stop opioid painkillers (codeine, tramadol, morphine)
from working. Never start it while taking any opioid, including buprenorphine or
methadone, because it can cause sudden withdrawal. Tell any surgeon, dentist or 
A&E team that you take it.

Naltrexone is a **blocker**. At the normal dose of 50 mg it is used to help people
with alcohol or opioid problems. "Low-dose" means about **1.5 to 4.5 mg**, roughly
a tenth of that. In the UK, using it this way is **off-label**: doctors can prescribe
it, but it is not licensed for these conditions.

### Theory 1: the short blackout

Drag the slider through one day after a bedtime dose.

10 pm, dose taken

Illustration only. The curve shapes are drawn to explain the theory. They are not
measured blood levels or receptor data.

The dose briefly blocks the opioid locks.

The idea, from **Ian Zagon and Patricia McLaughlin** at Penn State, is that a short
block makes the body react by making more of its own opioids and more locks. After
the drug wears off, you are left with a stronger natural system [Ref: Zagon & McLaughlin,
Life Sciences 1984;35:2057–64].

**Honest point:** this rebound has been shown in animals. Nobody has properly measured
it in patients.

### Theory 2: calming the brain's immune cells

The brain has its own immune cells, called **microglia**. When they are irritated
they release chemicals that make pain louder. Naltrexone can block an alarm switch
on these cells called **TLR4**, and that reversed pain in rats [Ref: Hutchinson 
et al., European Journal of Neuroscience 2008] [Ref: Wang et al., British Journal
of Pharmacology 2016;173(5):856–69].

**Honest point:** the rats received much more drug than a 1.5–4.5 mg tablet puts
into a human. That dose gap is the biggest hole in the LDN story.

### Theory 3: a growth brake

One of your natural keys, met-enkephalin, also slows how fast some cells divide,
including immune cells. LDN may adjust this brake [Ref: Zagon & McLaughlin, Life
Sciences 1984;35:2057–64]. This theory is mainly used to explain effects in gut 
and immune diseases.

### Does it actually work? The scoreboard

These verdicts are a plain-English judgement of the published trials. They are not
a score from any official body.

Fibromyalgia

Mixed: best trial negative

What the trials found

Randomised crossover

31 people

In a small 2013 trial of 31 women, pain dropped about 29% on LDN against 18% on 
placebo [Ref: Younger et al., Arthritis & Rheumatism 2013;65(2):529–38].

Randomised, double-blind

99 people

Best quality so far

A bigger, better 2024 trial of 99 women on 6 mg found **no real difference** from
placebo for pain [Ref: Due Bruun et al., Lancet Rheumatology 2024;6(1):e31–9]. When
two trials disagree, the better one counts more.

Crohn's disease

Weak: two small trials

What the trials found

Systematic review

Two small trials

A Cochrane review found only very small trials. They hint at benefit and are too
weak to be sure [Ref: Parker et al., Cochrane Database of Systematic Reviews 2018,
CD010410].

Multiple sclerosis

Weak: small trials, no effect on disease

What the trials found

Small pilot trials

Small trials showed slight improvements in how people felt, and no proof that it
slows the disease [Ref: Cree et al., Annals of Neurology 2010].

Long COVID, ME/CFS

Very weak: no placebo-controlled proof yet

What the trials found

Clinic reports

No placebo group

Mostly reports from clinics, without placebo comparisons. Larger trials are under
way. Treat claims online with caution.

**Bottom line:** LDN is cheap and usually well tolerated. The best evidence so far
is mixed to negative. Some people say it helps them, but nobody can yet promise 
it will help you. The most common side effect is vivid dreams or broken sleep in
the first weeks.

The best-known clinical researcher in this area is **Jarred Younger** (now at the
University of Alabama at Birmingham).

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#keys-locks)

[ Next: buprenorphine → ](https://clearingintheforest.org/your-own-painkillers/#buprenorphine)

## Buprenorphine: the half-turn key

**⚠ Safety first.** Buprenorphine is an opioid, and your body can become dependent
on it. With alcohol, sleeping tablets or benzodiazepines it can stop your breathing.
Never stop it suddenly without your prescriber.

Buprenorphine does two jobs at once:

### At the mu lock

It grips **very tightly** but turns the lock only **part-way**. You get some relief,
and the effect hits a ceiling. That ceiling makes it much less likely than morphine
or heroin to stop your breathing _when taken on its own_.

### At the kappa lock

It **blocks** the misery switch. Many scientists think this is why people describe
it as calming and why it may lift mood.

**Why sources disagree:** some papers call buprenorphine a "kappa partial agonist".
Technically it turns the kappa lock a tiny amount, so little that in practice it
acts as a blocker. Both descriptions are about the same drug, seen at different 
levels of detail.

Because it grips so tightly, it pushes other opioids off the lock. That is why it
is used to treat opioid addiction. It does not change nerve cells in some hidden
way. It works directly on the locks.

### Could it treat depression?

Randomised, double-blind

142 people

Funded by the drug maker

A 2016 trial added a tiny dose of buprenorphine, plus a second drug to stop the "
high", to antidepressants in people who had not got better. Their mood improved 
at the lower dose [Ref: Fava et al., American Journal of Psychiatry 2016;173(5):
499–508]. In 2019 the US regulator (FDA) still refused to approve the combination,
because the overall evidence was not strong enough.

**Not a casual drug.** Buprenorphine is still an opioid. Your body can become dependent
on it. Mixed with alcohol, sleeping tablets or benzodiazepines such as diazepam,
it can stop your breathing. Only take it as prescribed.

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#ldn)

[ Next: stay safe → ](https://clearingintheforest.org/your-own-painkillers/#stay-safe)

## Stay safe: tick each point once you have read it

   **LDN blocks opioid painkillers.** Codeine, tramadol, morphine and similar drugs
may not work while you take it.  **Never start LDN while taking opioids**, including
buprenorphine or methadone. It can throw you into sudden withdrawal.  **Tell your
surgeon, dentist or A&E** that you take LDN. They may need to stop it before an 
operation.  **Don't stop or change any medicine** without talking to your prescriber.**
Buprenorphine plus alcohol or sedatives** is a dangerous mix.  **A medicine is one
tool.** Movement, sleep, people who care about you and talking therapy all feed 
the same natural system.

✅ All six points read.

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#buprenorphine)

[ Next: quick quiz → ](https://clearingintheforest.org/your-own-painkillers/#quiz)

## Quick quiz

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#stay-safe)

[ References → ](https://clearingintheforest.org/your-own-painkillers/#references)

## References

 1.  [Ref: Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science
     1973;179:1011–14]
 2.  [Ref: Hughes J, Smith TW, Kosterlitz HW, et al. Identification of two related 
     pentapeptides from the brain with potent opiate agonist activity. Nature 1975;258:
     577–80]
 3.  [Ref: Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet
     1978;2(8091):654–7]
 4.  [Ref: Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia
     by naloxone. Pain 1983;16:129–43]
 5.  [Ref: Boecker H, et al. The runner's high: opioidergic mechanisms in the human
     brain. Cerebral Cortex 2008;18(11):2523–31]
 6.  [Ref: Hsu DT, et al. Response of the μ-opioid system to social rejection and acceptance.
     Molecular Psychiatry 2013;18(11):1211–17]
 7.  [Ref: Hsu DT, et al. It still hurts: altered endogenous opioid activity in the
     brain during social rejection and acceptance in major depressive disorder. Molecular
     Psychiatry 2015;20:193–200]
 8.  [Ref: Zagon IS, McLaughlin PJ. Naltrexone modulates body and brain development
     in rats: a role for endogenous opioid systems in growth. Life Sciences 1984;35:
     2057–64]
 9.  [Ref: Hutchinson MR, et al. Non-stereoselective reversal of neuropathic pain by
     naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). European 
     Journal of Neuroscience 2008;28:20–29]
 10. [Ref: Wang X, et al. Pharmacological characterization of the opioid inactive isomers(
     +)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. British
     Journal of Pharmacology 2016;173(5):856–69]
 11. [Ref: Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment
     of fibromyalgia. Arthritis & Rheumatism 2013;65(2):529–38]
 12. [Ref: Due Bruun K, et al. Naltrexone 6 mg once daily versus placebo in women with
     fibromyalgia: a randomised, double-blind, placebo-controlled trial. Lancet Rheumatology
     2024;6(1):e31–9]
 13. [Ref: Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N. Low dose naltrexone
     for induction of remission in Crohn's disease. Cochrane Database of Systematic
     Reviews 2018;CD010410]
 14. [Ref: Cree BAC, Kornyeyeva E, Goodin DS. Pilot trial of low-dose naltrexone and
     quality of life in multiple sclerosis. Annals of Neurology 2010;68:145–50]
 15. [Ref: Fava M, et al. Opioid modulation with buprenorphine/samidorphan as adjunctive
     treatment for inadequate response to antidepressants. American Journal of Psychiatry
     2016;173(5):499–508]

This page is for education. It is not personal medical advice. Talk to your own 
doctor or pharmacist about any medicine.

[ ← Back ](https://clearingintheforest.org/your-own-painkillers/#quiz)

[ Start again ↺ ](https://clearingintheforest.org/your-own-painkillers/#top)

Written by **Dr Saal Seneviratne**, Consultant Psychiatrist at [The Burlington Clinic](https://www.theburlingtonclinic.com),
London · Last reviewed 21 October 2026 · [About these pages](https://clearingintheforest.org/about/)
